SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Membrane and cell surface proteins and peptides (2046)
(-)
Fold: Toxins' membrane translocation domains (135)
(-)
Superfamily: Bcl-2 inhibitors of programmed cell death (113)
(-)
Family: Bcl-2 inhibitors of programmed cell death (102)
(-)
Protein domain: Apoptosis regulator Bcl-w (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (3)
1MK3A:SOLUTION STRUCTURE OF HUMAN BCL-W PROTEIN
1O0LA:THE STRUCTURE OF BCL-W REVEALS A ROLE FOR THE C-TERMINAL RESIDUES IN MODULATING BIOLOGICAL ACTIVITY
1ZY3A:1-170STRUCTURAL MODEL OF COMPLEX OF BCL-W PROTEIN WITH BID BH3-PEPTIDE
(-)
Protein domain: Apoptosis regulator Bcl-xL (38)
(-)
Human (Homo sapiens) [TaxId: 9606] (28)
1BXLA:STRUCTURE OF BCL-XL/BAK PEPTIDE COMPLEX, NMR, MINIMIZED AVERAGE STRUCTURE
1G5JA:COMPLEX OF BCL-XL WITH PEPTIDE FROM BAD
1LXLA:NMR STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH, MINIMIZED AVERAGE STRUCTURE
1MAZA:X-RAY STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH
1R2DA:STRUCTURE OF HUMAN BCL-XL AT 1.95 ANGSTROMS
1R2EA:HUMAN BCL-XL CONTAINING A GLU TO LEU MUTATION AT POSITION 92
1R2GA:HUMAN BCL-XL CONTAINING A PHE TO TRP MUTATION AT POSITION 97
1R2HA:HUMAN BCL-XL CONTAINING AN ALA TO LEU MUTATION AT POSITION 142
1R2IA:HUMAN BCL-XL CONTAINING A PHE TO LEU MUTATION AT POSITION 146
1YSGA:SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH "SAR BY NMR" LIGANDS
1YSIA:SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND
1YSNA:SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL COMPLEXED WITH AN ACYL-SULFONAMIDE-BASED LIGAND
2B48A:1-196BCL-XL 3D DOMAIN SWAPPED DIMER
2LPCA:NMR STRUCTURE OF BCL-XL
2O1YA:SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND
2O2MA:SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND
2O2NA:SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND
2P1LA:; C:; E:; G:STRUCTURE OF THE BCL-XL:BECLIN 1 COMPLEX
2PONB:SOLUTION STRUCTURE OF THE BCL-XL/BECLIN-1 COMPLEX
2YXJA:; B:CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH ABT-737
3CVAX:HUMAN BCL-XL CONTAINING A TRP TO ALA MUTATION AT POSITION 137
3IO8A:; C:BIML12F IN COMPLEX WITH BCL-XL
3PL7A:; B:CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH THE BAXBH3 DOMAIN
3QKDA:; B:CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH A QUINAZOLINE SULFONAMIDE INHIBITOR
3SP7A:CRYSTAL STRUCTURE OF BCL-XL BOUND TO BM903
3SPFA:CRYSTAL STRUCTURE OF BCL-XL BOUND TO BM501
3WIZA:; B:CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH COMPOUND 10
4EHRA:CRYSTAL STRUCTURE OF BCL-XL COMPLEX WITH 4-(5-BUTYL-3-(HYDROXYMETHYL)-1-PHENYL-1H-PYRAZOL-4-YL)-3-(3,4-DIHYDRO-2(1H)-ISOQUINOLINYLCARBONYL)-N-((2-(TRIMETHYLSILYL)ETHYL)SULFONYL)BENZAMIDE
(-)
Mouse (Mus musculus) [TaxId: 10090] (9)
1PQ0A:CRYSTAL STRUCTURE OF MOUSE BCL-XL
1PQ1A:CRYSTAL STRUCTURE OF BCL-XL/BIM
3IHCA:CRYSTAL STRUCTURE OF MOUSE BCL-XL (WT) AT PH 5.0
3IHDA:CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (Y101A) AT PH 5.0
3IHFA:; B:; C:; D:CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (R139A) AT PH 5.0
3IIGA:CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (F105A) AT PH 5.0
3IIHA:CRYSTAL STRUCTURE OF MOUSE BCL-XL (WT) AT PH 6.0
3ILBA:; N:CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (R139A) AT PH 6.0
3ILCA:CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (Y101A) AT PH 6.0
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (1)
1AF3A:RAT BCL-XL AN APOPTOSIS INHIBITORY PROTEIN
(-)
Protein domain: Apoptosis regulator ced-9 (2)
(-)
Nematode (Caenorhabditis elegans) [TaxId: 6239] (2)
1OHUA:; B:STRUCTURE OF CAENORHABDITIS ELEGANS CED-9
1TY4A:; B:CRYSTAL STRUCTURE OF A CED-9/EGL-1 COMPLEX
(-)
Protein domain: automated matches (33)
(-)
Human (Homo sapiens) [TaxId: 9606] (31)
2KBWA:SOLUTION STRUCTURE OF HUMAN MCL-1 COMPLEXED WITH HUMAN BID_BH3 PEPTIDE
2M03A:SOLUTION STRUCTURE OF BCL-XL DETERMINED WITH SELECTIVE ISOTOPE LABELLING OF I,L,V SIDECHAINS
2W3LA:; B:CRYSTAL STRUCTURE OF CHIMAERIC BCL2-XL AND PHENYL TETRAHYDROISOQUINOLINE AMIDE COMPLEX
2Y6WA:; B:STRUCTURE OF A BCL-W DIMER
2YJ1A:; C:PUMA BH3 FOLDAMER IN COMPLEX WITH BCL-XL
3FDLA:BIM BH3 PEPTIDE IN COMPLEX WITH BCL-XL
3FDMA:; B:; C:ALPHA/BETA FOLDAMER IN COMPLEX WITH BCL-XL
3INQA:; B:CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH W1191542
3IO9A:BIML12Y IN COMPLEX WITH MCL-1
3KJ0A:MCL-1 IN COMPLEX WITH BIM BH3 MUTANT I2DY
3KJ1A:MCL-1 IN COMPLEX WITH BIM BH3 MUTANT I2DA
3KJ2A:MCL-1 IN COMPLEX WITH BIM BH3 MUTANT F4AE
3KZ0A:; B:MCL-1 COMPLEX WITH MCL-1-SPECIFIC SELECTED PEPTIDE
3MK8A:THE MCL-1 BH3 HELIX IS AN EXCLUSIVE MCL-1 INHIBITOR AND APOPTOSIS SENSITIZER
3R85A:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN SOUL BH3 DOMAIN IN COMPLEX WITH BCL-XL
3WIXA:; B:; C:; D:CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 4
3WIYA:; B:; C:; D:; E:; F:CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 10
3ZK6A:; B:CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH INHIBITOR (COMPOUND 2).
3ZLNA:CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH INHIBITOR (COMPOUND 3).
3ZLOA:CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH INHIBITOR (COMPOUND 6).
3ZLRA:; B:CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH INHIBITOR (WEHI-539). 539).
4A1UA:CRYSTAL STRUCTURE OF ALPHA-BETA-FOLDAMER 2C IN COMPLEX WITH BCL-XL
4A1WA:; B:; C:; D:CRYSTAL STRUCTURE OF ALPHA-BETA FOLDAMER 4C IN COMPLEX WITH BCL-XL
4AQ3A:; B:; C:; D:; E:; F:HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR
4C52A:; B:CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH BENZOYLUREA COMPOUND (39B)
4C5DA:; B:CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH BENZOYLUREA COMPOUND (42)
4HW2A:; B:; C:; D:; E:; F:DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN
4HW3A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN
4IEHA:CRYSTAL STRUCTURE OF HUMAN BCL-2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR TARGETING BCL-2 BH3 DOMAIN INTERACTIONS
4OQ5A:; B:; C:; D:; E:; F:CRYSTAL STRUCTURE OF HUMAN MCL-1 BOUND TO INHIBITOR 4-(4-METHYLNAPHTHALEN-1-YL)-2-{[(4-PHENOXYPHENYL)SULFONYL]AMINO}BENZOIC ACID
4OQ6A:; B:CRYSTAL STRUCTURE OF HUMAN MCL-1 BOUND TO INHIBITOR 4-HYDROXY-4'-PROPYLBIPHENYL-3-CARBOXYLIC ACID
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
2BZWA:THE CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH FULL-LENGTH BAD
(-)
Nematode (Caenorhabditis elegans) [TaxId: 6239] (1)
2A5YA:STRUCTURE OF A CED-4/CED-9 COMPLEX
(-)
Protein domain: Bcl-2 (9)
(-)
Human (Homo sapiens) [TaxId: 9606] (9)
1G5MA:HUMAN BCL-2, ISOFORM 1
1GJHA:HUMAN BCL-2, ISOFORM 2
1YSWA:SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 COMPLEXED WITH AN ACYL-SULFONAMIDE-BASED LIGAND
2O21A:SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND
2O22A:SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND
2O2FA:SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND
4LVTA:; B:BCL_2-NAVITOCLAX (ABT-263) COMPLEX
4LXDA:BCL_2-NAVITOCLAX ANALOG (WITHOUT THIOPHENYL) COMPLEX
4MANA:; B:BCL_2-NAVITOCLAX ANALOG (WITH INDOLE) COMPLEX
(-)
Protein domain: Bcl-2 homolog (1)
(-)
Kaposi's sarcoma-associated herpesvirus [TaxId: 37296] (1)
1K3KA:SOLUTION STRUCTURE OF A BCL-2 HOMOLOG FROM KAPOSI'S SARCOMA VIRUS
(-)
Protein domain: Bcl-2 homolog V-bcl-2 (3)
(-)
Murid herpesvirus 4 [TaxId: 33708] (3)
2ABOA:6-136NMR STRUCTURE OF GAMMA HERPESVIRUS 68 A VIRAL BCL-2 HOMOLOG
3BL2A:; B:CRYSTAL STRUCTURE OF M11, THE BCL-2 HOMOLOG OF MURINE GAMMA-HERPESVIRUS 68, COMPLEXED WITH MOUSE BECLIN1 (RESIDUES 106-124)
3DVUA:; B:CRYSTAL STRUCTURE OF THE COMPLEX OF MURINE GAMMA-HERPESVIRUS 68 BCL-2 HOMOLOG M11 AND THE BECLIN 1 BH3 DOMAIN
(-)
Protein domain: Early antigen protein R (1)
(-)
Epstein-Barr virus [TaxId: 10376] (1)
1Q59A:SOLUTION STRUCTURE OF THE BHRF1 PROTEIN FROM EPSTEIN-BARR VIRUS, A HOMOLOG OF HUMAN BCL-2
(-)
Protein domain: EAT/MCL-1 (Myeloid cell leukemia sequence 1) (8)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
2PQKA:X-RAY CRYSTAL STRUCTURE OF HUMAN MCL-1 IN COMPLEX WITH BIM BH3
(-)
Mouse (Mus musculus) [TaxId: 10090] (5)
1WSXA:SOLUTION STRUCTURE OF MCL-1
2JM6B:SOLUTION STRUCTURE OF MCL-1 COMPLEXED WITH NOXAB
2ROCA:SOLUTION STRUCTURE OF MCL-1 COMPLEXED WITH PUMA
2RODA:SOLUTION STRUCTURE OF MCL-1 COMPLEXED WITH NOXAA
3D7VA:CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH AN MCL-1 SELECTIVE BH3 LIGAND
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (2)
2NL9A:CRYSTAL STRUCTURE OF THE MCL-1:BIM BH3 COMPLEX
2NLAA:CRYSTAL STRUCTURE OF THE MCL-1:MNOXAB BH3 COMPLEX
(-)
Protein domain: Proapoptotic molecule Bax (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1F16A:SOLUTION STRUCTURE OF A PRO-APOPTOTIC PROTEIN BAX
2K7WA:BAX ACTIVATION IS INITIATED AT A NOVEL INTERACTION SITE
(-)
Protein domain: Proapoptotic molecule Bid (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
2BIDA:HUMAN PRO-APOPTOTIC PROTEIN BID
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1DDBA:STRUCTURE OF MOUSE BID, NMR, 20 STRUCTURES